News
Artificial intelligence (AI) helped develop Pirelli's tires of the future, its new-generation P Zero product line, in record ...
AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.
Startup Persist AI, which launched a cloud lab to accelerate pharmaceutical formulation development, raised $12 million in a ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today ...
4d
GlobalData on MSNPharma’s AI prospects get nudged into the future with EU’s AI actExperts predict growing pains as the life sciences sector moves to adapt to the EU AI Act. The EU Artificial Intelligence (AI ...
Imagene is the Innovation award winner in the Precision Oncology category in the 2025 Pharmaceutical Excellence Awards.
1d
Free Malaysia Today on MSNFirst AI-generated drugs may reach market by 2030, says Insilico CEOThe pharmaceutical industry has long touted the promise of AI in slashing time and costs in the research and development ...
3don MSNOpinion
Europe's path to AI competitiveness lies in cutting red tape that hinders startups, not in removing AI safeguards.
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) decreased by 17.43 percent on Tuesday to finish at $29.60 apiece following the ...
The funding round was led by Spero Ventures with participation from MBX Capital, Shimadzu Future Innovation Fund managed by Global Brain Corporation, Eli Lilly & Company, SignalFire, Ford Street ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results